	Label	Description
	G59324HL Compound (Entity type)	type="BaseComposition" mass="2368.80319191" permass="2985.49179499" monosaccharides="14" is_motif="F...
	G88989HA Compound (Entity type)	type="Composition" mass="3568.24846174" permass="4437.21876607" monosaccharides="18" is_motif="False...
	q9ubz4-1 89asn 89asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification
	APEX2 HUMAN Protein (Entity type)	DNA-(apurinic or apyrimidinic site) endonuclease 2
	q9ubz4-1 361asn 361asn defined go:0006486 go:0006487 Post Translational Modification (Entity type)	A Post Translational Modification

G59324HL

type="BaseComposition" mass="2368.80319191" permass="2985.49179499" monosaccharides="14" is_motif="F...

G88989HA

type="Composition" mass="3568.24846174" permass="4437.21876607" monosaccharides="18" is_motif="False...

q9ubz4-1 89asn 89asn defined go:0006486 go:0006487

A Post Translational Modification

APEX2 HUMAN

DNA-(apurinic or apyrimidinic site) endonuclease 2

q9ubz4-1 361asn 361asn defined go:0006486 go:0006487

A Post Translational Modification

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.